Chapter 7 Part 3 Flashcards

1
Q

What is the stepwise acquisition of mutations that lead to the development of cancer?

A
  1. Initial carcinogen induced mutation
  2. mutation affecting genomic integrity
  3. additional driver mutations, acquisition of cancer hallmarks
  4. Additional mutations and emergence of subclones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Eight fundamental changes in cell physiology considered hallmarks of CA

A
  1. self-sufficiency in growth signals
  2. Insensitivity to growth-inhibitory signals
  3. altered cell metabolism
  4. Evasion of apoptosis
  5. Limitless replicative potential
  6. sustained angiogenesis
  7. ability to invade and metastasize
  8. ability to evade host immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a proto-oncogene?

A

growth promoter, involved in normal cell division and growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an oncogene?

A

cancer-causing gene, promote autonomous growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What allelic mutations are needed to promote neoplasia?

A

Conversion of one of two alleles from proto-oncogene to an oncogene, or loss of both tumor suppressor alleles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an oncoprotein?

A

resembles normal product of proto-oncogenes but contains mutations that inactivate internal regulatory elements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mode of action of growth factor oncogene

A

Growth factors can acquire the ability to synthesize their own growth factors and cause autocrine stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mode of action of growth factor receptor oncogene

A

constiutive, growth-factor independent tyrosine kinase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

EGFR1 gene product and associated CA

A

epidermal growth factor receptor, lung adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

EGFR2 gene product and associated CA

A

HER2 tyrosine kinase, amplified in breast carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALK proto-oncogene activation and associated CA

A

translocation or fusion with EML4, associated with lymphomas and adenocarcinomas of the lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Function of RAS proteins

A

signal transduction from RTKs to MAPK/PI3K pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Common point mutation result of RAS proteins

A

decreased GTPase activity resulting in constitutive pro-growth signals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cancers associated with RAS protein mutations

A

colon, lung, pancreatic, bladder, kidney, melanomas, hematologic, pituitary, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Result of activating BRAF mutation

A

downstream kinase and transcription factor activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mode of activation of BRAF and associated CAs

A

point mutation, melanomas, leukemias, colon carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ABL tyrosine kinase mode of activation and associated CA

A

translocation of gene from C9 to C22 - BCR-ALK gene product, acute lymphoblastic leukemias and chronic myelogenous leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Main actions of MYC

A

activates genes involved in cell growth – protein synthesis, cell cycle progression; upregulates telomerase, reprogram somatic cells to stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MYC mechanism of activation in tumor and associated CA

A

translocation, Burkitt lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CA associated with constiutive Wnt signaling

A

colon carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CA associated with constiutive HH signaling

A

meduloblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Mechanism of activation in tumor of cyclin and associated CA

A

Translocation - mantle cell lymphoma and multiple myeloma

Amplification - breast and esophageal CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mechanism of activation in tumor of CDKs and associated CA

A

amplification or pt mutation, glioblastoma, melanoma, sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Main function of RB

A

tumor suppressor protein that binds E2F transcription factors in hypophosphorylated state to prevent G1/S transition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Main function of p53

A

tumor suppressor, acts through p21 to cause cell cycle arrest, causes apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Proto-Oncogene mutations result in…

A

excessive increase in one or more normal functions encoded in gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

tumor-suppressor mutations result in…

A

lack of growth inhibition, requires both alleles to be damages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

mutations in genes that regulate apoptosis result in…

A

less death, enhanced survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

mutations in DNA-repair genes result in…

A

impaired ability to recognize and repair nonlethal genetic damage, can result in genetic instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

APC function

A

inhibit WNT signaling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

APC familial syndromes and CAs

A

familial colonic polyps and carcinomas, carcinomas of stomach, colon, pancreas; melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

NF1 function

A

inhibit RAS/MAPK signaling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

NF2 function

A

cytoskeletal stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

NF1 familial syndromes and CAs

A

neurofibromatosis type 1; neuroblastoma, juvenile myeloid lukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

NF2 familial syndromes and CAs

A

Neurofibromatosis type 2; schwannoma, meningioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

PTCH function

A

inhibitor of HH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

PTCH familial syndromes and CAs

A

Gorlin syndrome; basal cell carcinoma, medulloblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

VHL function

A

inhibitor of hypoxia induced transcription factors

39
Q

VHL familial syndromes and CAs

A

Von Hippel Lindau syndrome; renal cell carcinomas

40
Q

CDH1 function

A

cell adhesion, inhibition of cell motility

41
Q

CDH1 familial syndromes and CAs

A

familial gastric CA; gastric carcinoma, lobular breast carcinokma

42
Q

BRCA1 / BRCA 2 function

A

repair ds DNA breaks

43
Q

BRCA1/2 familial syndromes and CAs

A

familial breast and ovarian carcinoma, carcinomas of male breast, chronic lymphocytic leukemia; sporadic CA development rare

44
Q

MSH function

A

DNA mismatch repair

45
Q

MSH familial syndromes and CAs

A

hereditary nonpolyposis colon carcinoma; colonic and endometrial carcinoma

46
Q

WT1 function

A

transcription factor

47
Q

WT1 familial syndrome and CAs

A

familial wilms tumor; wilms tumor, certain leukemias

48
Q

What mutations are required to produce retinoblastoma?

A

two hits involving both RB alleles at 13q14

49
Q

Function of PD-1

A

checkpoint protein on T cells that prevent T cells from attacking other cells in the body by binding to PD-L1

50
Q

Mabs for PD-1

A

block binding of PD-1 to PD-L1 to bosst immune response to CA cells

51
Q

CTLA4 function

A

downregulate immune response, upregulated on T cells after activation

52
Q

Problem with CTLA4 Mab

A

serious and life-threatening side effects

53
Q

PDE4 function

A

degrades cAMP in immune cells, prevents anti-inflammatory effects - psoriatic lesion development

54
Q

Epigenome

A

factors other than DNA sequence that regulate gene expression

55
Q

Methylation of DNA

A

causes changes in DNA structure and thus causes activation or silencing of genes

56
Q

Histone acetylation

A

causes changes in chromatin regulatory complexes activating or silencing genes

57
Q

miRNAs

A

function to modulate translation of mRNAs into their proteins, posttranscriptional silencing of gene expression

58
Q

long noncoding RNA

A

modulate gene expression by binding to chromatin, restricting RNA polymerase access to coding genes

59
Q

Warburg effect

A

increased lactose production in the presence of glucose via the glycolytic pathway, demonstrates “glucose hunger” of tumors

60
Q

Is Warburg metabolism cancer specific?

A

No, it also occurs in growing cells (embryonic)

61
Q

What does Warburg metabolism provide for a cell that oxidative phosphorylation does not?

A

metabolic intermediates needed for synthesis of cellular components

62
Q

Role of PI3K/AKT in Warburg effect

A

upregulates glucose transports, glycolytic enzymes, shunts intermediates

63
Q

Role of RTK activity in Warburg effect

A

upregulate enzymatic activity leading to a build up of glycolytic intermediates

64
Q

Role of MYC activity in Warburg effect

A

upregulation of glutaminase and glycolytic enzymes

65
Q

How can apoptosis be initiated?

A

intrinsic or extrinsic pathways

66
Q

Which pathway of apoptosis is more commonly mutated in lesions?

A

intrinsic

67
Q

What anti-apoptotic gene is most commonly overexpressed in B-cell lymphoma and why?

A

BCL2 due to a 14;18 translocation

68
Q

How do cancer stem cells arise?

A

through transformation of a normal stem cell or acquired genetic lesions

69
Q

What two lesions are commonly acquired in cancer cells that convey limitless replicative potential?

A

inactivated senescence signals and reactivated telomerase

70
Q

Why is angiogenesis important?

A

required for growth of tumors

71
Q

What triggers angiogenesis?

A

hypoxia via HIF-1a and VEGF

72
Q

Actions of p53 for angiogenesis

A

induces synthesis of angiogenesis inhibitor thrombospondin-1

73
Q

Actions of RAS, MYK, MAPK in angiogenesis

A

upregulate VEGF to stimulate angiogenesis

74
Q

VEGF treatment

A

inhibitors can be used to prolong the clinical course but are not curative

75
Q

What cells recognize tumor ags?

A

CD8 T cells

76
Q

Classes of tumor antigens

A

products of mutated proto-oncogenes, tumor suppressor genes, overexpressed proteins, tumor ags produced by oncogenic viruses, oncofetal antigens, altered glycolipids and glycoproteins and cell-specific differentiation antigens

77
Q

What types of cancer are immunocompromised pts at an increased risk for?

A

oncogenic DNA viruses

78
Q

how may tumors avoid the immune system?

A

reduced expression of histocompatabilty antigens, immunosuppression expression, selective outgrowth of antigen-negative variants

79
Q

HNPCC syndrome

A

hereditary nonpolyposis colon cancer; defects in mismatch repair systems leading to carcinomas of colon

80
Q

xeroderma pigmentosum

A

defect in nt excision repair, increased risk for skin cancer due to inability to repair pyrimidine dimers

81
Q

Defects in homologous recombination DNA repair system constitute what disorders?

A

Bloom syndrome, ataxia-telangiectasia, fanconi anemia

82
Q

DNA damage in B and T lymphocyte tumors

A

occurs due to presence of products that induce genetic instability (RAG1, RAG2, AID)

83
Q

CA enabling effects of inflammatory cells

A

release of factors that promote proliferation, removal of growth suppressors, enhanced resistance to cell death (anoikis), inducing angiogenesis, activating invasion and metastasis, evading immune destruction

84
Q

oncogenic mutations

A

point mutations, chromosomal abnormalities, translocations, deletions, amplifications

85
Q

How do balanced translocations contribute to carcinogenesis?

A

overexpression of oncogenes or fusion protein generation with altered signaling capacity

86
Q

How do deletions contribute to carcinogenesis?

A

loss of tumor suppressor gene function, activation of proto-oncogenes

87
Q

How do amplifications cause carcinogenesis?

A

increased expression and function of oncogenes

88
Q

chromothrypsis

A

shattered chromosome reassembled in haphazard way

89
Q

Translocation of CML

A

9;22

90
Q

Translocation of AML

A

8;21 or 15;17

91
Q

Translocation of burkitt lymphoma

A

8;14

92
Q

Translocation of Mantle cell lymphoma

A

11;14

93
Q

Translocation of follicular lymphoma

A

14;18

94
Q

All-trans retinoic acid in acute promyelocytic leukemia

A

used to activate gene transcription to activate PMNs, PML+RARa translocation normally prevents gene expression with normal RA but ATRA allows for transcription